CME/SAM. Expression of Hepatocyte Antigen in Small Intestinal Epithelium and Adenocarcinoma
|
|
- Annis Copeland
- 6 years ago
- Views:
Transcription
1 Anatomic Pathology / Hepatocyte Antigen Expression in Intestine Expression of Hepatocyte Antigen in Small Intestinal Epithelium and Adenocarcinoma Mylinh T. Mac, MD, 1 Fai Chung, 1 Fan Lin, MD, PhD, 2 Pei Hui, MD, PhD, 3 Bonnie L. Balzer, MD, 1 and Hanlin L. Wang, MD, PhD 1 Key Words: Small intestine; Colorectal; Adenocarcinoma; Carbamoyl phosphate synthetase 1; Hepatocyte antigen; Hep Par 1 DOI: /AJCPUD0P5NQBOYPK CME/SAM Upon completion of this activity you will be able to: describe the pattern of Hep Par 1 immunoreactivity in nonneoplastic small intestinal and colonic epithelium. define the usefulness of Hep Par 1 immunostaining in the differential diagnosis of various hepatocellular and nonhepatocellular neoplasms. Abstract Hepatocyte antigen is recognized by antibody Hep Par 1, a widely used diagnostic immunomarker for hepatocellular carcinoma and tumors with hepatoid differentiation. Hepatocyte antigen expression has also been detected in nonneoplastic small intestinal epithelium, but expression in small intestinal adenocarcinoma has not been well investigated. We immunohistochemically examined 39 nonampullary small intestinal adenocarcinomas for hepatocyte antigen expression; 34 cases contained normal-appearing nonneoplastic small intestinal mucosa on the same tissue sections. In 30 cases (88%), the nonneoplastic mucosa exhibited granular cytoplasmic Hep Par 1 staining exclusively in the epithelium. Only 9 small intestinal adenocarcinomas (23%) showed focal positive cytoplasmic staining. Nonneoplastic colonic epithelium was negative for Hep Par 1. In 31 colorectal adenocarcinomas, 3 (10%) showed positive staining for Hep Par 1 (1 diffuse, 2 focal), a frequency not different from that for small intestinal adenocarcinomas (P =.2467). Tumors expressing hepatocyte antigen did not exhibit evidence of hepatoid differentiation and were histologically indistinguishable from hepatocyte antigen negative tumors. Hepatocyte antigen immunoreactivity is selectively expressed in nonneoplastic small intestinal enterocytes but not in colonocytes, suggesting a potential physiologic role in intestinal biology. Whether the loss of antigen expression in a large number of small intestinal adenocarcinomas serves a role in small intestinal tumorigenesis remains to be investigated. The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit per article. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module. The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. Questions appear on p 145. Exam is located at Hepatocyte antigen is a mitochondrial-associated epitope recognized by a monoclonal antibody, hepatocyte paraffin 1 or Hep Par 1, which was generated using tissue extracts prepared from a formalin-fixed failed allograft liver. 1 Despite its diagnostic limitation in that it does not distinguish benign from malignant hepatocellular lesions, it has emerged as a frequently used immunomarker in surgical pathology to help separate hepatocellular mass lesions, particularly hepatocellular carcinoma, from nonhepatocellular neoplasms such as intrahepatic cholangiocarcinoma and metastatic carcinomas. 2,3 Numerous studies have shown that Hep Par 1 antibody is highly sensitive in the detection of hepatocellular carcinoma, with a detection rate of more than 90% in most series. 1,4-10 Only a few studies have reported a lower detection rate, ranging from 66% to 82% However, Hep Par 1 is not entirely specific. In addition to being frequently detected in extrahepatic hepatoid adenocarcinomas, 14 Hep Par 1 immunoreactivity has been occasionally demonstrated in nonhepatocellular neoplasms that lack overt hepatoid differentiation. 1,6,7,9,10,13,15 Surprisingly, the antigen recognized by Hep Par 1 remained elusive for more than a decade until recently. By using immunoprecipitation, mass spectrometry, and database search, Butler et al 16 demonstrated that the peptide sequences of the protein immunoprecipitated by Hep Par 1 matched that of carbamoyl phosphate synthetase 1 (CPS1), a ratelimiting enzyme of the urea cycle, with a very high degree of probability. While this discovery may satisfy the curiosity of pathologists and biomedical researchers, it raises a series of intriguing questions about the physiologic and pathogenetic roles of the protein. 17 This is so because even in normal human tissues, Hep Par 1 immunoreactivity is not entirely restricted to hepatocytes; it is also detected in small intestinal 80 Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK
2 Anatomic Pathology / Original Article epithelium. 1,13,16,18 In fact, Hep Par 1 has been suggested as a useful immunomarker to help detect intestinal metaplasia in Barrett esophagus and chronic gastritis. 18 Given its unique distribution in neoplastic and nonneoplastic tissues, we investigated the expression of hepatocyte antigen in small intestinal adenocarcinoma to determine whether the antigenicity would be preserved during small intestinal carcinogenesis similarly to that seen in hepatocarcinogenesis. Materials and Methods Tissue Samples We examined 39 cases of surgically resected primary adenocarcinoma of the small intestine. These included 21 cases from the jejunum, 7 from the ileum, 5 from the duodenum (distal from the ampulla of Vater), and 6 with unspecified location. Ampullary carcinomas were excluded from the study because of their heterogeneous histogenesis. Cases with a clinical history of adenocarcinoma in other anatomic locations were also excluded. For comparison, 31 surgically resected sporadic colorectal adenocarcinomas were randomly selected. H&E-stained slides were rereviewed to confirm the diagnosis. Formalin-fixed, paraffin-embedded tissue blocks were selected to include adenocarcinoma and normalappearing nonneoplastic intestinal mucosa in the same blocks, if possible. Immunohistochemical Staining Immunohistochemical staining was performed using the DAKO autostainer (DAKO, Carpinteria, CA). Briefly, 4-µm sections from formalin-fixed, paraffin-embedded tissue blocks were deparaffinized, rehydrated, and treated with 3% hydrogen peroxide for 10 minutes to inhibit endogenous peroxidase. Following heat-induced epitope retrieval in 10 mmol/l citrate buffer at ph 6.0 for 30 minutes, the slides were incubated with a mouse monoclonal antibody specific for human hepatocyte antigen (clone OCH1E5) obtained from DAKO with a dilution of 1:200 for 45 minutes at room temperature. The immunoreaction was performed using the mouse EnVision+ detection system that contained biotin-free horseradish peroxidase labeled polymers (DAKO). The staining was visualized using 3,39-diaminobenzidine substrate chromogen solution and counterstained with hematoxylin. For each batch of staining, a negative control sample was included in which the primary antibody was replaced by nonhuman-reactive mouse IgG. In addition, 26 cases of surgically resected hepatocellular carcinoma served as a control cohort. Nonneoplastic liver tissue was present on the same sections for each case. Immunohistochemically stained slides were analyzed by 2 observers (M.T.M. and H.L.W.), and cytoplasmic staining was considered positive. A case was considered negative if fewer than 5% of the cells of interest exhibited immunoreactivity. Positive stains were recorded as focal if 5% to 50% of the cells stained and diffuse if more than 50% of the cells showed immunoreactivity. Statistical Analysis Statistical analysis was performed by using the 2-tailed Fisher s exact test or the χ 2 test with Yates continuity correction. A P value of less than.05 was considered statistically significant. Results The patients with primary small intestinal adenocarcinoma ranged in age from 33 to 84 years (mean, 63 years; median, 68 years). Of the patients, 25 were men and 14 were women (M/F ratio, 1.8:1). Three cases were associated with Crohn disease, 1 with Gardner syndrome, and 1 with celiac disease. No known risk factors were identified in the remaining 34 cases. At the time of surgical resection, 2 cases were stage I, 17 stage II, 8 stage III, and 12 stage IV. Nine cases were well differentiated, 20 moderately differentiated, and 10 poorly differentiated. None of the patients with small intestinal or colorectal adenocarcinoma received preoperative neoadjuvant chemoradiation therapy. Of the 39 cases of small intestinal adenocarcinoma, 34 contained normal-appearing nonneoplastic small intestinal mucosa on the same tissue sections, of which 30 (88%) showed granular cytoplasmic staining for Hep Par 1 exclusively in the epithelium zimage 1Az. The staining was diffuse in 21 cases (70%) and focal in 9 cases (30%). The immunoreactivity tended to be stronger in villi and weaker in deep crypts and was not detected in microvilli zimage 1Bz. In contrast, the normal-appearing nonneoplastic colonic epithelium present in all 31 cases of colorectal adenocarcinoma was completely negative for Hep Par 1 zimage 1Cz. These data are summarized in ztable 1z. ztable 2z summarizes the findings of Hep Par 1 immunostaining in small intestinal and colorectal adenocarcinomas. Of 39 small intestinal adenocarcinomas, only 9 (23%) showed positive staining. This finding was in marked contrast with the frequency of positive Hep Par 1 staining in nonneoplastic small intestinal epithelium (P <.0001). In addition, all 9 tumors showed a focal staining pattern zimage 2Az, while the corresponding nonneoplastic epithelium exhibited a diffuse staining pattern in 6 cases (67%). In only 2 cases was positive Hep Par 1 staining detected in tumor cells but not in nonneoplastic epithelium. In the 30 cases that showed positive Hep Par 1 staining in nonneoplastic small intestinal epithelium, complete loss of Hep Par 1 immunoreactivity was observed in 23 corresponding adenocarcinomas (77%) zimage 2Bz. Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK 81
3 Mac et al / Hepatocyte Antigen Expression in Intestine As shown in Table 2, loss of Hep Par 1 immunoreactivity in small intestinal adenocarcinomas did not seem to be site-specific. Although duodenal adenocarcinomas seemed more likely to preserve Hep Par 1 antigenicity, as seen in 3 of 5 cases, there was no statistically significant difference when compared with jejunal (P =.0624) and ileal (P =.5581) adenocarcinomas. Loss of Hep Par 1 immunoreactivity was noted in all 5 tumors that were associated with Crohn disease, Gardner syndrome, and celiac disease. Of the 31 colorectal adenocarcinomas, 3 (10%) showed positive Hep Par 1 immunostaining, 1 diffuse zimage 2Cz and 2 focal. The frequency of Hep Par 1 positivity in colorectal adenocarcinomas was similar to that in small intestinal adenocarcinomas (P =.2470). In both types of adenocarcinoma, A B C zimage 1z A, Diffuse immunostaining pattern for hepatocyte paraffin (Hep Par) 1 in nonneoplastic small intestinal mucosa ( 100). B, Hep Par 1 staining in nonneoplastic enterocytes was diffusely cytoplasmic and granular ( 600) and spared microvilli (arrow). C, The nonneoplastic colonic mucosa was completely negative for Hep Par 1 immunoreactivity ( 200). ztable 1z Hepatocyte Paraffin 1 Expression in Nonneoplastic Small Intestinal and Colorectal Epithelia Small Intestine Immunoreactivity Duodenum (n = 4) Jejunum (n = 19) Ileum (n = 5) Unspecified (n = 6) Total (n = 34) Colorectum (n = 31) Negative Focal Diffuse Positive (%) Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK
4 Anatomic Pathology / Original Article there was no discernible histologic difference between Hep Par 1 positive and Hep Par 1 negative tumors. None of the tumors exhibited histologic evidence of hepatoid differentiation. In the control cohort, 24 (92%) of 26 hepatocellular carcinomas showed strong cytoplasmic staining for Hep Par 1. The staining was diffuse in 18 cases (75%) and focal in 6. The nonneoplastic liver tissue was diffusely and strongly positive in all cases, including the 2 cases with negative immunoreactivity in hepatocellular carcinoma. Discussion Since its discovery in 1993 by Wennerberg and colleagues, 1 Hep Par 1 has become a widely used antibody ztable 2z Hepatocyte Paraffin 1 Expression in Small Intestinal and Colorectal Adenocarcinomas Small Intestine Immunoreactivity Duodenum (n = 5) Jejunum (n = 21) Ileum (n = 7) Unspecified (n = 6) Total (n = 39) Colorectum (n = 31) Negative Focal Diffuse Positive (%) A C B zimage 2z A, Focal hepatocyte paraffin (Hep Par) 1 positivity in a small intestinal adenocarcinoma ( 200). B, Loss of Hep Par 1 immunoreactivity in a small intestinal adenocarcinoma ( 100). Note the positive staining in nonneoplastic small intestinal mucosa overlying the tumor (upper area). C, Diffuse Hep Par 1 immunostaining in a colonic adenocarcinoma ( 200). Note that the nonneoplastic colonic mucosa (right lower area) was completely negative for Hep Par 1. Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK 83
5 Mac et al / Hepatocyte Antigen Expression in Intestine in surgical pathology as a relatively sensitive and specific marker of hepatocellular differentiation. Recently, Butler et al 16 expanded our knowledge by identifying its antigen as a rate-limiting enzyme of the urea cycle, CPS1. Since it is believed that converting ammonia to urea takes place only in hepatocytes in humans, it is difficult to understand why Hep Par 1 immunoreactivity is also detected in small intestinal mucosa. 1,13,16,18 It is also unclear whether this enzyme serves any role in carcinogenesis, given its occasional expression in a variety of nonhepatocellular neoplasms. 1,6,7,9,10,13,15 In this study, we immunohistochemically examined hepatocyte antigen expression in a large number of small intestinal adenocarcinomas and nonneoplastic small intestinal mucosa. Our findings extend the previous observations and confirm that Hep Par 1 antibody recognizes an epitope in nonneoplastic small intestinal epithelium that is absent in nonneoplastic colonic epithelium. In addition, our results demonstrate a frequent loss of Hep Par 1 immunoreactivity in small intestinal adenocarcinomas. Although the presence of CPS1 in human enterocytes was convincingly demonstrated by immunoprecipitation and Western blot analysis at the protein level in the study by Butler et al, 16 it has not been examined at the functional level. It also remains to be investigated whether other critical urea cycle enzymes are present in human enterocytes. Therefore, it is unknown at present whether a functional urea cycle exists in human small intestinal epithelium, although the existence has been suggested in postweaning pigs. 19 It is possible that CPS1 may serve an alternative role in small intestinal physiology, instead of participating in a nitrogen-processing pathway as in the liver. It is also possible that there is another protein or epitope unique to the small intestinal epithelium that shares enough homology with CPS1 to cross-react with Hep Par 1 antibody. This latter possibility seems unlikely, however, given the similar molecular weight (~165 kda) of the protein band on Western blot and the same granular cytoplasmic staining pattern in immunohistochemical analysis recognized by Hep Par 1 and anti-cps1 antibodies. 16 Additional studies at the messenger RNA level may be helpful in this regard. In our study, focal and negative stains for Hep Par 1 in nonneoplastic small intestinal mucosa were noted in 9 (26%) and 4 (12%) cases, respectively. A focal staining pattern was also reported by Wennerberg et al. 1 It is unclear why the staining was diffuse in the majority of the cases but focal or even negative in others. We cannot completely exclude the effect of certain technical factors, such as varied tissue fixation. We also speculate that variation in the physiologic status of the enterocytes in different people may contribute because the expression of the cps1 gene has been shown to be subject to physiologic regulation. 20 Understanding the physiologic function(s) of CPS1 in the small intestine may be necessary to explain the variable immunostaining patterns. There have been only 2 studies, to our knowledge, that have examined hepatocyte antigen expression in a total of 17 small intestinal adenocarcinomas. 1,13 In the study by Wennerberg et al, 1 all 6 tumors (duodenum, 3; jejunum, 2; ileum, 1) were negative for Hep Par 1. By using tissue microarray analysis, Lugli et al 13 demonstrated positive staining in 4 (36%) of 11 tumors. In line with these observations, we detected focal Hep Par 1 immunoreactivity in 9 (23%) of 39 small intestinal adenocarcinomas. The frequency of hepatocyte antigen expression in colorectal adenocarcinomas in our study (10%) is also similar to that reported in other series. 9,13 In contrast with hepatocarcinogenesis in which Hep Par 1 immunoreactivity is well preserved, the current study clearly demonstrates a frequent loss of Hep Par 1 immunoreactivity in small intestinal adenocarcinoma. While this finding may simply represent an epiphenomenon during tumor progression, it raises an intriguing question whether hepatocyte antigen (or CPS1) serves a role in small intestinal tumorigenesis. This finding also provides an additional line of evidence to substantiate previous observations that small intestinal adenocarcinoma is pathogenetically and immunophenotypically distinct from colorectal adenocarcinoma, despite their morphologic similarity Furthermore, loss of Hep Par 1 immunoreactivity may have potential usefulness in confirming the diagnosis of small intestinal adenocarcinoma on challenging biopsy specimens. Our study demonstrates that hepatocyte antigen is expressed in nonneoplastic small intestinal epithelium but not in nonneoplastic colonic mucosa and that the immunoreactivity is frequently lost in small intestinal adenocarcinoma. These observations may have important implications in the understanding of the physiologic, pathologic, and tumorigenic roles of CPS1 in the small intestine, which warrant additional investigations. From the Departments of 1 Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; 2 Laboratory Medicine, Geisinger Medical Center, Danville, PA; and 3 Pathology, Yale University School of Medicine, New Haven, CT. Presented in abstract form at the annual meeting of the United States and Canadian Academy of Pathology; March 1-7, 2008; Denver, CO. Address reprint requests to Dr Wang: Dept of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA References 1. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol. 1993;143: Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK
6 Anatomic Pathology / Original Article 2. Wee A. Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics. Appl Immunohistochem Mol Morphol. 2006;14: Kakar S, Gown AM, Goodman ZD, et al. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med. 2007;131: Wu PC, Fang JW, Lau VK, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers: clinical and biological implications. Am J Pathol. 1996;149: Leong AS, Sormunen RT, Tsui WM, et al. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998;33: Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alphafetoprotein. Am J Surg Pathol. 2002;26: Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33: Morrison C, Marsh W Jr, Frankel WL. A comparison of CD10 to pcea, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol. 2002;15: Fan Z, van de Rijn M, Montgomery K, et al. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16: Kakar S, Muir T, Murphy LM, et al. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol. 2003;119: Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol. 1997;10: Wieczorek TJ, Pinkus JL, Glickman JN, et al. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol. 2002;118: Lugli A, Tornillo L, Mirlacher M, et al. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol. 2004;122: Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol. 2001;115: Villari D, Caruso R, Grosso M, et al. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Pathology. 2002;34: Butler SL, Dong H, Cardona D, et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab Invest. 2008;88: Wang HL. Inside Lab Invest: disclosing the identity of hepatocyte paraffin 1 antigen. Lab Invest. 2008;88: Chu PG, Jiang Z, Weiss LM. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol. 2003;27: Wu G. Urea synthesis in enterocytes of developing pigs. Biochem J. 1995;312: Tillman JB, Dhahbi JM, Mote PL, et al. Dietary calorie restriction in mice induces carbamyl phosphate synthetase I gene transcription tissue specifically. J Biol Chem. 1996;271: Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004;28: Chen ZM, Ritter JH, Wang HL. Differential expression of alpha-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines. Am J Surg Pathol. 2005;29: Zhang MQ, Chen ZM, Wang HL. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma. Mod Pathol. 2006;19: Zhang MQ, Lin F, Hui P, et al. Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma. Am J Clin Pathol. 2007;128: Am J Clin Pathol 2009;132: DOI: /AJCPUD0P5NQBOYPK 85
Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material
508 Al-Muhannadi N, et al., 2011; 10 (4): 508-515 ORIGINAL ARTICLE October-December, Vol. 10 No.4, 2011: 508-515 Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical
More informationComparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma
Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma Thuy Nguyen, MD; Daniel Phillips, MD; Dhanpat Jain, MD; Michael Torbenson, MD;
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationWT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids
Anatomic Pathology / WT1, ESTROGEN RECEPTOR, AND PROGESTERONE RECEPTOR IN CYTOLOGY OF BODY FLUIDS WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More information8 years later! Next Generation Sequencing. Pathogenic Findings: HNF1A c.864delinscc, p.g292rfs*25 (NM_ ) (VAF: 59%) HNF1A Loss
8 years later! Next Generation Sequencing Pathogenic Findings: HNF1A c.864delinscc, p.g292rfs*25 (NM_000545.6) (VAF: 59%) HNF1A Loss Interpretation HNF1A c.864delinscc, p.g292rfs*25 (NM_000545.6) This
More informationLiver Specialty Evening Conference. Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle
Liver Specialty Evening Conference Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle Case History A 65 year-old man presents with abdominal
More informationTissue-Specific Cadherin CDH17 Is a Useful Marker of Gastrointestinal Adenocarcinomas With Higher Sensitivity Than CDX2
Anatomic Pathology / CDH17 in Gastrointestinal Carcinomas Tissue-Specific Cadherin CDH17 Is a Useful Marker of Gastrointestinal Adenocarcinomas With Higher Sensitivity Than CDX2 Nicole C. Panarelli, MD,
More informationMalignant neoplasms of the gastrointestinal (GI) tract,
Special Section First Chinese American Pathologists Association Diagnostic Pathology Course, Part II Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary
More informationSenior of Histopathology Department at Khartoum, Radiation and Isotopes Center
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 2/ May 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Immune Histochemical Evaluation of AMACR (P504S) in Prostatic Adenocarcinoma
More informationROLE OF TTF-1, CK20, AND CK7 IMMUNOHISTOCHEMISTRY FOR DIAGNOSIS OF PRIMARY
Y.C. Su, Y.C. Hsu, and C.Y. Chai ROLE OF TTF-1, CK20, AND CK7 IMMUNOHISTOCHEMISTRY FOR DIAGNOSIS OF PRIMARY AND SECONDARY LUNG ADENOCARCINOMA Yue-Chiu Su 1, Yu-Chang Hsu 2, and Chee-Yin Chai 1,3 Departments
More informationImmunohistochemical Characterization of Signet-Ring Cell Carcinomas of the Stomach, Breast, and Colon
Anatomic Pathology / SIGNET-RING CELL CARCINOMAS OF THE STOMACH, BREAST, AND COLON Immunohistochemical Characterization of Signet-Ring Cell Carcinomas of the Stomach, Breast, and Colon Peiguo G. Chu, MD,
More informationImmunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers
Immunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers Ana I. Porcell L., M.D., Barry R. De Young, M.D., Daniela M. Proca,
More informationImmunohistochemical Evaluation of Necrotic Malignant Melanomas
Anatomic Pathology / EVALUATION OF NECROTIC MALIGNANT MELANOMAS Immunohistochemical Evaluation of Necrotic Malignant Melanomas Daisuke Nonaka, MD, Jordan Laser, MD, Rachel Tucker, HTL(ASCP), and Jonathan
More informationProstate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue
IHC Interpretation: General Principles (1) Prostate Immunohistochemistry Murali Varma Cardiff, UK wptmv@cf.ac.uk Sarajevo Nov 2013 Must be aware of staining pattern of antibody in the relevant tissue Nuclear/cytoplasmic/membranous
More informationDifferential diagnosis of HCC
Hepatocellular Carcinoma Quest for an Ideal Immunohistochemical Panel Sanjay Kakar, MD UCSF Differential diagnosis of HCC Hepatocellular lesions Adenoma, FNH, HG dysplasia Adenocarcinoma CholangioCA, metastasis
More informationInterpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma. PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use
Interpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use For countries outside of the United States, see the local
More informationCD15 and CEA expression in thymic epithelial neoplasms
Turkish Journal of Cancer Volume 8, No., 8 CD and CEA expression in thymic epithelial neoplasms AYTEKİN AKYOL, AYŞEGÜL ÜNER Hacettepe University, Department of Pathology, Ankara-Turkey ABSTRACT The aim
More informationPrimary Liver Carcinoma Arising in People Younger Than 30 Years
Anatomic Pathology / PRIMARY LIVER CARCINOMA Primary Liver Carcinoma Arising in People Younger Than 30 Years Walter M. Klein, MD, 1 Ernesto P. Molmenti, MD, 2 Paul M. Colombani, MD, 2 Davinder S. Grover,
More informationSingle and Multiplex Immunohistochemistry
Single and Multiplex Immunohistochemistry Steve Westra, BS Reagent Product Specialist Leica Biosystems IHC Theory Polyclonal vs Monoclonal Polyclonal reagents Detect a multitude of epitopes Batch to batch
More informationExpression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Peiguo G. Chu, M.D., Ph.D., Lawrence M. Weiss, M.D. Department of Pathology, City of Hope National Medical Center,
More information2018 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist - Volume II
Release Date: January 1, 15.25 AMA PRA Category 1 Credit(s) TM About This CME Teaching Activity This CME Activity is designed to provide a comprehensive review of soft tissue, gastrointestinal, genitourinary,
More informationHepatocyte Antigen Expression in Subtypes of Intestinal Metaplasia of the Stomach
ORIGINAL ARTICLES Hepatocyte Antigen Expression in Subtypes of Intestinal Metaplasia of the Stomach GA Gokhan Ocak 1, G Yildirim 2, GO Elpek 1 ABSTRACT Objective: Recently, hepatocyte antigen (Hep) was
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationCase history: Figure 1. H&E, 5x. Figure 2. H&E, 20x.
1 Case history: A 49 year-old female presented with a 5 year history of chronic anal fissure. The patient s past medical history is otherwise unremarkable. On digital rectal examination there was a very
More informationNordic Immunohistochemical Quality Control
Nordic Immunohistochemical Quality Control Immunohistochemistry in the classifiation of neoplasias of the alimentary tract & External Quality Assurance of Immunohistochemistry for GI cancer markers Mogens
More informationACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION
POL J PATHOL 2011; 2: 95-100 ACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION OF MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS FERESHTEH ENSANI, FARNAZ NEMATIZADEH, GITI IRVANLOU Department of Cytology, Cancer
More informationBrief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies
Brief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies Victoria Sujoy, MD, Mehrdad Nadji, MD, and Azorides R. Morales, MD From
More informationA Chronic or Recurring Pattern of Esophagitis Resembling Allergic Contact Dermatitis
Anatomic Pathology / Lymphocytic Esophagitis Lymphocytic Esophagitis A Chronic or Recurring Pattern of Esophagitis Resembling Allergic Contact Dermatitis Julianne K. Purdy, MD, Henry D. Appelman, MD, Christopher
More informationCarcinoembryonic antigen (CEA)
Assessment Run 37 2013 Carcinoembryonic antigen (CEA) Material The slide to be stained for CEA comprised: 1. Appendix, 2. Liver, 3-4. Colon adenocarcinoma, 5. Urothelial carcinoma All tissues were fixed
More informationCase report. Open Access. Abstract
Open Access Case report Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report Chih-Wen Lin 1, Chia-Chang Hsu 1, Hong-Cheng Chang 2, Yu-Chiun Sun
More informationNEW IHC A n t i b o d i e s
NEW IHC Antibodies TABLE OF CONTENTS NEW IHC ANTIBODIES from Cell Marque CITED1 (5H6).... 1 Claudin 7 (5D10F3).... 1 GATA1 (4F5).... 1 Transgelin (2A10C2).... 1 NEW IHC ANTIBODIES using RabMAb Technology
More informationValue of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationreact with these antibodies. Reports from different recent review Crocker and Burnett suggested that
JClin Pathol 1989;42:1096-1 100 Laboratory techniques Comparative quality assessment in immunocytochemistry: pilot study of CD15 staining in paraffin wax embedded tissue in Hodgkin's disease CAROLE A ANGEL,
More informationAnti-PD-L1 antibody [28-8] ab205921
Anti-PD-L1 antibody [28-8] ab205921 2 Abreviews 16 References 15 Images Overview Product name Anti-PD-L1 antibody [28-8] Description Tested applications Species reactivity Immunogen Rabbit monoclonal [28-8]
More informationTitle:COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis
Author's response to reviews Title:COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis Authors: Ewa Pomianowska (ewa.pomianowska@medisin.uio.no) Aasa R
More informationImmunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors.
ISPUB.COM The Internet Journal of Pathology Volume 13 Number 2 Immunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors. A Baghla, S Choudhry, A Kataria Citation A Baghla, S Choudhry,
More informationSerotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum
2012 66 4 351 356 Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum a b* c c c a a b d a c b d 352 Ohara et al. received remedies at another hospital. Hematemesis then recurred
More informationNovocastra Liquid Mouse Monoclonal Antibody MyoD1 (Rhabdomyosarcoma Marker)
Novocastra Liquid Mouse Monoclonal Antibody MyoD1 (Rhabdomyosarcoma Marker) Product Code: NCL-L-MyoD1 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW
More informationSAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST QUESTIONS. Ver. #
SAMs Guidelines DEVELOPING SELF-ASSESSMENT MODULES TEST Ver. #5-02.12.17 GUIDELINES FOR DEVELOPING SELF-ASSESSMENT MODULES TEST The USCAP is accredited by the American Board of Pathology (ABP) to offer
More informationP rimary and metastatic malignant tumours of the liver
1069 ORIGINAL ARTICLE Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma C Röcken, J Licht, A Roessner, S Carl-McGrath... See end of article for authors
More informationAmerican Journal of. Medical Case Reports. CAM5.2 Expression in Metastatic Tumours of CNS: A Diagnostic Tool
American Journal of American Journals of Medical Case Reports http://ivyunion.org/index.php/ajmcr/index Medical Case Reports Mathur SK et al. American Journal of Medical Case Reports 2014, 2:1-8 Vol 2,
More information# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer
#1034 - Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer Richard W. Cartun, MS, PhD Andrew Ricci, Jr, MD Department of Pathology Hartford
More informationNovocastra Liquid Mouse Monoclonal Antibody Cytokeratin (5/6/18)
Novocastra Liquid Mouse Monoclonal Antibody Cytokeratin (5/6/18) Product Code: NCL-L-LP34 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW United Kingdom
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationPitfalls in the diagnosis of well-differentiated hepatocellular lesions
2013 Colorado Society of Pathology Pitfalls in the diagnosis of well-differentiated hepatocellular lesions Sanjay Kakar, MD University of California, San Francisco Outline Hepatocellular adenoma: new WHO
More informationPanels of Immunohistochemical Markers Help Determine Primary Sites of Metastatic Adenocarcinoma
Panels of Immunohistochemical Markers Help Determine Primary Sites of Metastatic Adenocarcinoma Seog-Yun Park, MD; Baek-Hee Kim, MD; Jung-Ho Kim, MD; Sun Lee, MD; Gyeong Hoon Kang, MD Context. Although
More informationAssessment Run CK19
Assessment Run 29 200 CK9 The slide to be stained for CK9 comprised:. Appendix, 2. Thyroid gland, 3. Pancreas, 4. Ductal breast carcinoma, 5. Esophagus, 6. Papillary thyroid carcinoma. All tissues were
More informationThe determination of estrogen (ER) and progesterone receptor
The Utility of Estrogen Receptor and Progesterone Receptor Immunohistochemistry in the Distinction of Metastatic Breast Carcinoma From Other Tumors in the Liver Jason W. Nash, DO; Carl Morrison, MD; Wendy
More informationNovocastra Liquid Mouse Monoclonal Antibody Multi-Cytokeratin (4/5/6/8/10/13/18)
Novocastra Liquid Mouse Monoclonal Antibody Multi-Cytokeratin (4/5/6/8/10/13/18) Product Code: NCL-L-C11 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW
More informationDetection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell lung Cancer (NSCLC) By CISH Technique
Cancer and Clinical Oncology; Vol. 7, No. 1; 2018 ISSN 1927-4858 E-ISSN 1927-4866 Published by Canadian Center of Science and Education Detection of Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell
More informationMucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationImmunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on
Supplemental Methods Immunohistochemical Analyses Immunostaining was performed on tumor biopsy samples arranged in a tissue-microarray format or on prostatectomy sections obtained post-study. Briefly,
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationSAM PROVIDER TOOLKIT
THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational
More informationHepPar1, MOC-31, pcea, mcea and CD10 for Distinguishing Hepatocellular Carcinoma vs. Metastatic Adenocarcinoma in Liver Fine Needle Aspirates
HepPar1, MOC-31, pcea, mcea and CD10 for Distinguishing Hepatocellular Carcinoma vs. Metastatic Adenocarcinoma in Liver Fine Needle Aspirates Luoquan Wang, M.D., Magalis Vuolo, M.D., Mark J. Suhrland,
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationVariable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin Eva Compérat
More informationGastroenterology Tutorial
Gastroenterology Tutorial Gastritis Poorly defined term that refers to inflammation of the stomach. Infection with H. pylori is the most common cause of gastritis. Most patients remain asymptomatic Some
More informationImmunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics
Anatomic Pathology / CLAUDIN-1 IN MENINGIOMAS Immunohistochemical Staining for Claudin-1 Can Help Distinguish Meningiomas From Histologic Mimics Hejin P. Hahn, MD, PhD, Elizabeth A. Bundock, MD, PhD, and
More informationNovocastra Liquid Mouse Monoclonal Antibody Carcinoembryonic Antigen (CD66e)
Novocastra Liquid Mouse Monoclonal Antibody Carcinoembryonic Antigen (CD66e) Product Code: NCL-L-CEA-2 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW
More informationExpression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens
The Korean Journal of Pathology 2006; 40: 32-8 Expression of the GLUT1 and p53 Protein in Atypical Mucosal Lesions Obtained from Gastric Biopsy Specimens In Gu Do Youn Wha Kim Yong-Koo Park Department
More informationThe Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast Carcinoma
Anatomic Pathology / Fixation Effects on ER and PR in Breast Cancer The Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast
More informationDisclosure of Relevant Financial Relationships
Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS
More informationLactase, sucrase-isomaltase, and carbamoyl phosphate synthase I expression in human intestine van Beers, E.H.
UvA-DARE (Digital Academic Repository) Lactase, sucrase-isomaltase, and carbamoyl phosphate synthase I expression in human intestine van Beers, E.H. Link to publication Citation for published version (APA):
More informationWendy L Frankel. Chair and Distinguished Professor
1 Wendy L Frankel Chair and Distinguished Professor Case 1 59 y/o woman Abdominal pain No personal or family history of cancer History of colon polyps Colonoscopy Polypoid rectosigmoid mass Biopsy 3 4
More informationLIST OF ORGANS FOR HISTOPATHOLOGICAL ANALYSIS:!! Neural!!!!!!Respiratory:! Brain : Cerebrum,!!! Lungs and trachea! Olfactory, Cerebellum!!!!Other:!
LIST OF ORGANS FOR HISTOPATHOLOGICAL ANALYSIS:!! Neural!!!!!!Respiratory:! Brain : Cerebrum,!!! Lungs and trachea! Olfactory, Cerebellum!!!!Other:! Spinal cord and peripheral nerves! Eyes, Inner ear, nasal
More informationCluster designation 5 staining of normal and non-lymphoid neoplastic skin*
J Cutan Pathol 2005: 32: 50 54 Copyright # Blackwell Munksgaard 2005 Blackwell Munksgaard. Printed in Denmark Journal of Cutaneous Pathology Cluster designation 5 staining of normal and non-lymphoid neoplastic
More informationINTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)
INTRODUCTION TO PATHOLOGICAL TECHNIQUES 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH) Biopsy-Indications Diffuse/multifocal lesions (neoplastic, inflammatory, etc) Etiology of the
More informationGastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis
Br. J. Cancer (1986) 53, 189-195 Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis C. Haglund1, J. Lindgren2, P.J. Roberts1 and S. Nordling3
More informationDistinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationImportance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms
ONCOLOGY LETTERS 9: 1583-1589, 2015 Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms TAKAHIRO EINAMA 1,2,3, HIROFUMI KAMACHI 1, HIROSHI NISHIHARA 4, SHIGENORI
More informationCarcinoembryonic Antigen
Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring
More informationCase 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:
Case 18 M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: A. Pilomatrical carcinoma B. Adnexal carcinoma NOS C. Metastatic squamous cell carcinoma D.Primary squamous cell carcinoma
More informationNehal A Radwan * and Naglaa S Ahmed
Radwan and Ahmed Diagnostic Pathology 2012, 7:149 RESEARCH Open Access The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma
More informationNavigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction
Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction Ann S. Fulcher, MD Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Objectives To
More informationImmunohistochemistry on Fluid Specimens: Technical Considerations
Immunohistochemistry on Fluid Specimens: Technical Considerations Blake Gilks Dept of Pathology University of British Columbia, Vancouver, BC, Canada Disclosures None Learning Objectives At the end of
More informationPD-L1 IHC 22C3 pharmdx. SK tests for use with Autostainer Link 48 Table of Contents
PD-L1 IHC 22C3 pharmdx SK006 50 tests for use with Autostainer Link 48 Table of Contents 1 Intended Use... 2 2 Summary and Explanation... 2 2.1 NSCLC... 2 2.2 Gastric or Gastroesophageal Junction (GEJ)
More informationMorphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens
ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens C Rose, H Wu Citation C Rose, H Wu.. The Internet Journal of Pathology.
More informationNovocastra Liquid Mouse Monoclonal Antibody CD71
Novocastra Liquid Mouse Monoclonal Antibody CD71 Product Code: NCL-L-CD71-309 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW United Kingdom ( +44 191
More informationTable of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS
Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec
More informationSonic hedgehog expression in gastric cancer and gastric adenoma
ONCOLOGY REPORTS 17: 1051-1055, 2007 Sonic hedgehog expression in gastric cancer and gastric adenoma SUN-YOUNG LEE 1, HYE SEUNG HAN 2, KYUNG YUNG LEE 3, TAE SOOK HWANG 2, JEONG HWAN KIM 1, IN-KYUNG SUNG
More informationDepartment of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan
Malaysian J Pathol 2014; 36(3) : 169 173 ORIGINAL ARTICLE Application of combined immunohistochemical panel of AMACR(P504S)/p63 cocktail, cytokeratin 5 and D2-40 to atypical glands in prostatic needle
More informationROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS
Original Research Article Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS SUBATHRA K* Department of pathology,
More informationGOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationGOBLET CELL CARCINOID
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationWhat Every Pathologist Wants the GI Nurse to Know (and how you can help us help you)
What Every Pathologist Wants the GI Nurse to Know (and how you can help us help you) Jonathan N. Glickman MD PhD Director, GI Pathology, Caris Diagnostics, Newton, MA Associate Professor of Pathology,
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationThe clinically challenging entity of liver metastasis from tumors of unknown primary
The clinically challenging entity of liver metastasis from tumors of unknown primary Xuchen Zhang, MD, PhD Associate Professor of Pathology Department of Pathology Yale University School of Medicine Liver
More informationHercepTest for the Dako Autostainer Code K5207
HercepTest for the Dako Autostainer Code K5207 9th edition For immunocytochemical staining. The kit is for 50 tests (100 slides). (126659-002) P04088US_02_K520721-5/2016.05 p. 1/54 Contents Page Intended
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationGLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q
The British Association of Plastic Surgeons (2005) 58, 348 352 GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations q J. Leon-Villapalos a, K. Wolfe b, L. Kangesu
More informationNovocastra Liquid Mouse Monoclonal Antibody p57 Protein (Kip2)
Novocastra Liquid Mouse Monoclonal Antibody p57 Protein (Kip2) Product Code: NCL-L-p57 Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW United Kingdom
More informationExpression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract
PATHOLOGY RESEARCH AND PRACTICE Urban & Fischer Verlag http://www.urbanfischer.de/journals/prp Original Paper Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract Daniela Cabibi
More information